Adolor Corporation to Host Investor Conference Call to Report Year-End 2009 Financial Results
February 18 2010 - 4:44PM
Business Wire
Adolor Corporation (NasdaqGM: ADLR) today announced that it will
hold a conference call at 8:45 a.m. ET on Thursday, February 25,
2010, to discuss year-end 2009 financial results.
To participate in the audio portion and have the opportunity to
pose questions, dial 800-706-7741 for domestic callers or
617-614-3471 for international callers, and enter Conference ID #
47374449. Investors also can listen to the call live by logging on
to the Company’s website at www.adolor.com and clicking on
“Investor Insights,” then “Calendar of Events.”
A replay of the call will be available beginning approximately
two hours after the event. To listen to a replay of the conference
call, dial 888-286-8010 (domestic) or 617-801-6888 (international)
and enter Conference ID # 42905736 or listen via Adolor’s website.
The replay will be available for one week.
About Adolor Corporation
Adolor Corporation is a biopharmaceutical company specializing
in the discovery, development and commercialization of novel
prescription pain management products.
Adolor’s first approved product in the United States is ENTEREG®
(alvimopan), which is indicated to accelerate the time to upper and
lower gastrointestinal recovery following partial large or small
bowel resection surgery with primary anastomosis. ENTEREG is
available for short-term use in hospitals registered under the
E.A.S.E.™ Program. For more information on ENTEREG, including its
full prescribing information, visit www.ENTEREG.com. In
collaboration with GlaxoSmithKline (GSK), the Company launched
ENTEREG in mid-2008.
The Company’s research and development pipeline includes: two
novel delta opioid receptor agonists, currently in mid-stage
clinical development in collaboration with Pfizer Inc. for chronic
pain; two opioid receptor antagonists, ADL7445 and ADL 5945,
entering development for chronic opioid bowel dysfunction (OBD);
and several opioid and non-opioid discovery programs.
For more information, visit www.adolor.com.
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jul 2023 to Jul 2024
